Channel Therapeutics Corporation

NYSE American: CHRO
Share price (3/25/25): $1.51
Market cap (3/25/25): $9.096 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Late annual filing notification for FY 2023

Prospectuses and Registrations Filter

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Notification of registration of securities for successor

Prospectus supplement

Ownership Filter

Ikarian Capital, LLC

Alexandra Wood (Canada) Inc.

Malamut Richard

Friedberg Ezra M

News Filter

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Financial Statements or Exhibits

Chromocell Announces Name Change to “Channel Therapeutics Corporation” and Provides Therapeutic Program Updates

Investor Presentation

Chromocell Announces Stock Repurchase Plan

Chromocell Announces Stock Repurchase Plan

Proxies Filter

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Notice of effectiveness